Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap7.53B
Enterprise Value7.03B
P/E Ratio-12.08
PEG Ratio0
Price/Sales Ratio9.76
Price/Book Ratio1.19
Enterprise/Revenue8.7
Enterprise/EBITDA-10.21

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.81
Operating Margin-1.15
AD

Management Effectiveness

Return On Assets-0.08
Return On Equity-0.09

Income Statement

Revenue623.64M
Revenue/Share0.55
Gross Profit387.56M
EBITDA164.13M
Net Income-347.2M
Diluted EPS-0.34

Balance Sheet

Total Cash1.16B
Total Cash/Share1.07
Total Debt17.89M
Total Debt/Equity0
Current Ratio3.38
Book Value Per Share4.74

Price History

52-Week Change-33.02
52-Week High9.4
52-Week Low4.81
Moving Average 50 Days5.77
Moving Average 200 Days6.82

Statistics

Average Volume46.84M
Shares Outstanding1.03B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.01
Trailing Annual Dividend Yield0.18
Payout Ratio-0.04
Last Split Factor3:2
Last Split DateJuly 04, 2019
AD